Leah J Blank1,2, Emily K Acton3,4,5,6, Dylan Thibault3,4,5,6, Allison W Willis3,4,5,6,7. 1. Department of Neurology, Division of Health Outcomes and Knowledge Translational Research, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2. Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 4. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 5. Department of Neurology Translational Center of Excellence for Neuroepidemiology and Neurological Outcomes Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 6. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 7. Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Abstract
OBJECTIVE: To determine the incidence of epilepsy among Medicare beneficiaries with a new diagnosis of Alzheimer dementia (AD) or Parkinson disease (PD). METHODS: Retrospective cohort study of Medicare beneficiaries with an incident diagnosis of AD or PD in the year 2009. The 5-year incidence of epilepsy was examined by sociodemographic characteristics, comorbidities and neurodegenerative disease status. Cox regression models examined the association of neurodegenerative disease with incident epilepsy, adjusting for demographic characteristics and medical comorbidities. RESULTS: We identified 178,593 individuals with incident AD and 104,157 individuals with incident PD among 34,054,293 Medicare beneficiaries with complete data in 2009. Epilepsy was diagnosed in 4.45% (7,956) of AD patients and 4.81% (5,010) of PD patients between 2009 and 2014, approximately twice as frequently as in the control sample. Minority race/ethnicity was associated with increased risk of incident epilepsy. Among individuals with AD and PD, stroke was associated with increased epilepsy risk. Traumatic brain injury (TBI) was associated with increased epilepsy risk for individuals with PD. Depression was also associated with incident epilepsy (AD adjusted hazard ratio (AHR): 1.23 (1.17-1.29), PD AHR: 1.45 (1.37-1.54)). In PD only, a history of hip fracture (AHR, 1.35 (1.17-1.57)) and diabetes (AHR, 1.11 (1.05-1.18) were also associated with increased risk of epilepsy. CONCLUSION: Incident epilepsy is more frequently diagnosed among neurodegenerative disease patients, particularly when preceded by a diagnosis of depression, TBI or stroke. Further studies into the differences in epilepsy risk between these two populations may help elucidate different mechanisms of epileptogenesis.
OBJECTIVE: To determine the incidence of epilepsy among Medicare beneficiaries with a new diagnosis of Alzheimer dementia (AD) or Parkinson disease (PD). METHODS: Retrospective cohort study of Medicare beneficiaries with an incident diagnosis of AD or PD in the year 2009. The 5-year incidence of epilepsy was examined by sociodemographic characteristics, comorbidities and neurodegenerative disease status. Cox regression models examined the association of neurodegenerative disease with incident epilepsy, adjusting for demographic characteristics and medical comorbidities. RESULTS: We identified 178,593 individuals with incident AD and 104,157 individuals with incident PD among 34,054,293 Medicare beneficiaries with complete data in 2009. Epilepsy was diagnosed in 4.45% (7,956) of ADpatients and 4.81% (5,010) of PDpatients between 2009 and 2014, approximately twice as frequently as in the control sample. Minority race/ethnicity was associated with increased risk of incident epilepsy. Among individuals with AD and PD, stroke was associated with increased epilepsy risk. Traumatic brain injury (TBI) was associated with increased epilepsy risk for individuals with PD. Depression was also associated with incident epilepsy (AD adjusted hazard ratio (AHR): 1.23 (1.17-1.29), PD AHR: 1.45 (1.37-1.54)). In PD only, a history of hip fracture (AHR, 1.35 (1.17-1.57)) and diabetes (AHR, 1.11 (1.05-1.18) were also associated with increased risk of epilepsy. CONCLUSION: Incident epilepsy is more frequently diagnosed among neurodegenerative diseasepatients, particularly when preceded by a diagnosis of depression, TBI or stroke. Further studies into the differences in epilepsy risk between these two populations may help elucidate different mechanisms of epileptogenesis.
Authors: David B Reuben; Carol P Roth; Janet C Frank; Susan H Hirsch; Diane Katz; Heather McCreath; Jon Younger; Marta Murawski; Elizabeth Edgerly; Joanne Maher; Katie Maslow; Neil S Wenger Journal: J Am Geriatr Soc Date: 2010-01-26 Impact factor: 5.562
Authors: Germaine Odenheimer; Soo Borson; Amy E Sanders; Rebecca J Swain-Eng; Helen H Kyomen; Samantha Tierney; Laura N Gitlin; Mary Ann Forciea; John Absher; Joseph Shega; Jerry Johnson Journal: Neurology Date: 2013-09-25 Impact factor: 9.910
Authors: Nikolaos Scarmeas; Lawrence S Honig; Hyunmi Choi; Julio Cantero; Jason Brandt; Deborah Blacker; Marilyn Albert; Joan C Amatniek; Karen Marder; Karen Bell; W Allen Hauser; Yaakov Stern Journal: Arch Neurol Date: 2009-08
Authors: Michael C Irizarry; Shelia Jin; Feng He; Jennifer A Emond; Rema Raman; Ronald G Thomas; Mary Sano; Joseph F Quinn; Pierre N Tariot; Douglas R Galasko; Lianna S Ishihara; John G Weil; Paul S Aisen Journal: Arch Neurol Date: 2012-03
Authors: C A Granbichler; W Oberaigner; G Kuchukhidze; J-P Ndayisaba; A Ndayisaba; A Taylor; G Bauer; G Luef; E Trinka Journal: Eur J Neurol Date: 2017-02-27 Impact factor: 6.089
Authors: Iris E Martínez-Juárez; Bianca Funes; Julio C Moreno-Castellanos; Elisa Bribiesca-Contreras; Verónica Martínez-Bustos; Lizeth Zertuche-Ortuño; Laura E Hernández-Vanegas; Lizbeth Hernandez Ronquillo; Syed Rizvi; Wu Adam; Jose F Tellez-Zenteno Journal: Epilepsia Open Date: 2017-10-19
Authors: Annika Ahtiainen; Barbara Genocchi; Jarno M A Tanskanen; Michael T Barros; Jari A K Hyttinen; Kerstin Lenk Journal: Int J Mol Sci Date: 2021-11-25 Impact factor: 5.923